ATLANTA, Dec. 4, 2019 /PRNewswire/ -- Oncology
Analytics, a leading technology-enabled service company that
provides health plans, providers, and patients with an
evidence-based, analytics focused approach to utilization
management, purpose-built for oncology, has announced the
appointment of Dr. Lee Newcomer as a
strategic advisor.
Dr. Newcomer is a board-certified oncologist with more than 30
years of experience in oncology management, first as a practicing
oncologist, and then in the healthcare industry, where he has been
instrumental in leading the charge for affordable and effective
cancer care.
Through his strategic advisor role with Oncology Analytics, he
will offer his extensive expertise in oncology benefits management
and precision medicine to help support the company's market and
product strategy. In addition, Dr. Newcomer will lead and chair the
creation of a Customer Advisory Board where customers will
collaborate with Oncology Analytics to provide feedback, identify
priorities, and help guide the company's future roadmap.
"Dr. Newcomer is a nationally recognized medical professional
and visionary with a strong track record of success in oncology
benefits management," said Rick
Dean, Oncology Analytics' CEO. "By combining his
medical background in oncology with his business acumen, he has
helped positively change the medical industry to take into account
both the payer and the patient perspective. We are honored to have
him as part of our team."
"For cancer patients to receive the right care, health plans
need to keep up with the rapid changes in therapies to ensure that
treatment recommendations are tailored to the specific needs of
their members," said Dr. Newcomer. "This is why I am excited to
work with Oncology Analytics, as their approach to prior
authorization goes beyond a simple yes or no. They understand
that a patient-first approach requires collaboration with
oncologists as part of the decision-making process. Oncology
Analytics' unique analytics-driven model is helping to positively
shape the future of cancer care."
Dr. Newcomer was most recently at UnitedHealth Group
(NYSE: UNH), where he began his career in 1991 as the Chief Medical
Officer. Dr. Newcomer practiced medical oncology
in Minneapolis and Tulsa, Oklahoma; he served as the Medical Director
for Cigna Healthcare in Kansas City; and he was a founding
executive of Vivius, a consumer-directed venture that allowed
consumers to create their own personalized health plans. In 2006,
Dr. Newcomer returned to UnitedHealth Group to lead a pilot
initiative combining clinical, financial, and program management
experts to improve the quality and affordability of cancer care.
During that time, the team launched the first risk payment
program for cancer therapy, created a physician-oriented prior
authorization tool, developed the first commercial database with
clinical and claims data for cancer patients, and launched a
genetic test management program.
About Oncology Analytics
Oncology Analytics, Inc. provides health plans, providers, and
patients with a data-driven, utilization management solution that
delivers real-world, evidence-based analytics-focused exclusively
for oncology. Used by physicians to support more than 4.3 million
health plan members in the US and Puerto
Rico, the Oncology Analytics e-Prior Authorization platform
covers the full spectrum of therapeutics, across all cancer types
and stages, including chemotherapy, radiation therapy, precision
medicine, targeted therapy, and supportive care. The extensive
pathway library is continuously updated with the latest
evidence-based protocols, which provides the most current options
for value-based treatment paths for every patient case. For more
information, please visit www.oncologyanalytics.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/oncology-analytics-appoints-dr-lee-newcomer-as-strategic-advisor-300968939.html
SOURCE Oncology Analytics, Inc.